ME Therapeutics Holdings Inc.
METX
CNSX
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 628.20K | 891.80K | 1.02M | 1.24M | 1.38M |
| Total Receivables | 26.80K | 37.70K | 49.60K | 24.50K | 16.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 54.70K | 16.00K | 22.60K | 22.90K | 42.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 709.70K | 945.50K | 1.09M | 1.29M | 1.44M |
|
|
|||||
| Total Current Assets | 709.70K | 945.50K | 1.09M | 1.29M | 1.44M |
| Net Property, Plant & Equipment | 163.40K | 158.60K | 179.40K | 166.00K | 170.10K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.00K | 7.80K | 7.90K | 7.90K | 7.50K |
| Total Assets | 881.10K | 1.11M | 1.28M | 1.46M | 1.62M |
|
|
|||||
| Total Accounts Payable | 61.70K | 94.30K | 113.00K | 33.30K | 5.70K |
| Total Accrued Expenses | 12.30K | 12.00K | 10.70K | 19.20K | 26.90K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 31.10K | 41.10K | 44.30K | 42.30K | 38.60K |
| Total Finance Division Other Current Liabilities | 10.80K | 10.50K | 10.70K | 10.70K | -- |
| Total Other Current Liabilities | 10.80K | 10.50K | 10.70K | 10.70K | -- |
| Total Current Liabilities | 115.90K | 157.90K | 178.60K | 105.50K | 71.30K |
|
|
|||||
| Total Current Liabilities | 115.90K | 157.90K | 178.60K | 105.50K | 71.30K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 7.90K | 19.60K | 29.40K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 115.90K | 157.90K | 186.50K | 125.10K | 100.70K |
|
|
|||||
| Common Stock & APIC | 6.54M | 6.38M | 6.25M | 6.24M | 5.95M |
| Retained Earnings | -7.56M | -7.17M | -7.08M | -6.83M | -6.26M |
| Treasury Stock & Other | 1.78M | 1.74M | 1.92M | 1.92M | 1.83M |
| Total Common Equity | 765.20K | 953.90K | 1.09M | 1.34M | 1.52M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 765.20K | 953.90K | 1.09M | 1.34M | 1.52M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 765.20K | 953.90K | 1.09M | 1.34M | 1.52M |
|
|
|||||